Establishing it as the first ever reusable intermittent urinary catheter system and creating a new device classification in an industry that exclusively relied on single-use catheters for decades
STRASBOURG, France and KITCHENER, ON, May 1, 2026 /PRNewswire/ — Qaelon Medical announced a strategic collaboration with leading surgical recovery company FluidAI Medical, to develop a continuous surgical data ecosystem.
Alzheimer’s disease agitation could mean peak sales of over $2.1 billion for Axsome’s Auvelity, according to analysts at William Blair.
When genes are transcribed, they suppress or activate their neighbors, coupling expression between the two genes.
Neural interaction with bacteria has important effects on animal brains. A new study investigates how neurons sense bacteria by revealing, in nematodes, the bacterial signals that a key neuron detects.
RNA therapy may calm abnormal brain activity of epilepsy in utero, before seizures emerge
The TAVVE study will begin later this year with ten patients, whose 30-day safety results will be submitted to the FDA.
https://med-techinsights.com/2026/04/22/new-tool-launches-to-support-women-through-post-loss-journey/
Orchestra BioMed (Nasdaq:OBIO) announced today that it received a second FDA breakthrough device designation for its AVIM therapy.
New research out of VCU Massey Comprehensive Cancer Center has uncovered a targeted cancer therapy that significantly prevents leukemia progression, improves survival rates and minimizes damage to surrounding healthy tissue.